TFC Financial Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.8K	Hold	72	–	–	﹤0.01%	340
2025 Q4	$28.6K	Sell	72 -2	-3%	-$885	﹤0.01%	322
2025 Q3	$33.7K	Hold	74	–	–	﹤0.01%	305
2025 Q2	$24.1K	Hold	74	–	–	﹤0.01%	323
2025 Q1	$20K	Hold	74	–	–	﹤0.01%	319
2024 Q4	$17.4K	Hold	74	–	–	﹤0.01%	329
2024 Q3	$20.4K	Buy	74 +20	+37%	+$5.21K	﹤0.01%	323
2024 Q2	$13.1K	Buy	54 +3	+6%	+$474	﹤0.01%	327
2024 Q1	$7.62K	Buy	51 +1	+2%	+$167	﹤0.01%	350
2023 Q4	$9.57K	Hold	50	–	–	﹤0.01%	333
2023 Q3	$8.86K	Hold	50	–	–	﹤0.01%	354
2023 Q2	$9.5K	Sell	50 -75	-60%	-$14.9K	﹤0.01%	337
2023 Q1	$25K	Hold	125	–	–	0.01%	291
2022 Q4	$29.7K	Hold	125	–	–	0.01%	233
2022 Q3	$25K	Hold	125	–	–	0.01%	237
2022 Q2	$18K	Hold	125	–	–	0.01%	262
2022 Q1	$20K	Hold	125	–	–	0.01%	254
2021 Q4	$21K	Hold	125	–	–	0.01%	273
2021 Q3	$24K	Hold	125	–	–	0.01%	254
2021 Q2	$21K	Hold	125	–	–	0.01%	260
2021 Q1	$18K	Hold	125	–	–	0.01%	262
2020 Q4	$16K	Hold	125	–	–	0.01%	271
2020 Q3	$18K	Buy	+125	New	+$17.8K	0.01%	240